Medicine / D-0838-2026
U.S. Food and Drug AdministrationD-0838-2026
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC…
Class III Ohio not named in distribution
Status: Ongoing
What was recalled
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
Recalling firm
Chiesi USA, Inc.
Reason for recall
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Where it went
MO, TN
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.